Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Cisplatin
  • Hyperthermia, Induced
  • Mitoxantrone
  • Peritoneal Neoplasms
  • Sarcoma

abstract

  • Although the HIPEC technique is feasible for patients with sarcomatosis, it is associated with significant toxicity and limited clinical benefit. Combination CDDP/MITOX failed to demonstrate any benefit over CDDP alone; moreover, there was an increase in toxicity.

publication date

  • August 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1245/s10434-007-9463-z

PubMed ID

  • 17541691

Additional Document Info

start page

  • 2309

end page

  • 18

volume

  • 14

number

  • 8